BioSpace News Archive

The U.S. Food and Drug Administration announced it issued three warning letters to companies for introducing mole and skin tag removal products into interstate commerce that are unapproved new drugs, in violation of the Federal Food, Drug, and Cosmetic Act.

The latest market analysis report published by Reports and Data, titled ‘Global Mild Dry Eyes Market – Forecast to 2030,’ thoroughly examines the Mild Dry Eyes industry to provide essential data & information for the targeted readers.

The latest market analysis report published by Reports and Data, titled ‘Global Dysthymia Market – Forecast to 2030,’ thoroughly examines the Dysthymia industry to provide essential data & information for the targeted readers.

The latest market analysis report published by Reports and Data, titled ‘Global Castration-Resistant Prostate Cancer Market – Forecast to 2030,’ thoroughly examines the Castration-Resistant Prostate Cancer industry to provide essential data & information for the targeted readers.

The latest market analysis report published by Reports and Data, titled ‘Global Atrial Flutter Treatment Market – Forecast to 2030,’ thoroughly examines the Atrial Flutter Treatment industry to provide essential data & information for the targeted readers.

Kurve Therapeutics, a next-generation medtech innovator focused on developing treatments for neurodegenerative diseases, announced it has filed a Form 1-A preliminary offering circular with the U.S. Securities and Exchange Commission (SEC) for a $50 million funding round [kurvetx.com/offering-circular] .

Applied DNA Sciences, Inc., a leader in polymerase chain reaction -based technologies, announced that The City University of New York, the largest urban university in the United States, has extended its health services contract for COVID-19 testing and vaccine policy management with the Company’s wholly-owned clinical laboratory subsidiary, Applied DNA Clinical Labs, LLC, for 12 months through July 2023 and at the prior contract terms.

Genixus™, a pharmaceutical company focused on transforming acute and critical care medicines, today announced that it will offer Propofol as the first product within its KinetiX™ platform of RTA syringe products at the Annual National Pharmacy Purchasing Association Conference (booth # 603-605).

Mindray North America, a global leader and developer of healthcare technologies and solutions for ultrasound, patient monitoring, and anesthesia, announced the launch of a new product that is changing the perspective in the Point of Care Ultrasound market: the TE X Ultrasound System.

Summit Therapeutics Inc. announced the successful closing of its fully-subscribed $100 million rights offering.